These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17722970)

  • 1. Drug-induced cardiovascular disorders.
    Murphy CA; Dargie HJ
    Drug Saf; 2007; 30(9):783-804. PubMed ID: 17722970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure induced by non-cardiac drugs.
    Slørdal L; Spigset O
    Drug Saf; 2006; 29(7):567-86. PubMed ID: 16808550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications.
    Brouillette J; Nattel S
    Can J Cardiol; 2017 Dec; 33(12):1577-1586. PubMed ID: 29173600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASSESSMENT OF ADVERSE DRUG REACTIONS AS CARDIOVASCULAR RISK FACTORS.
    Gavrilescu CM; Felea MG; Barbu R; Duma O; Bodescu MM; Midilina Bodescul M; Ghiuru R; Boerescu C; Paraschiv C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):48-54. PubMed ID: 27125072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
    Savage R
    Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain management today - what have we learned?
    Langford RM
    Clin Rheumatol; 2006; 25 Suppl 1():S2-8. PubMed ID: 16741780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
    Nurmohamed MT; van Halm VP; Dijkmans BA
    Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular side effects of psychopharmacologic therapy.
    Potočnjak I; Degoricija V; Vukičević Baudoin D; Čulig J; Jakovljević M
    Int J Cardiol; 2016 Sep; 219():367-72. PubMed ID: 27352209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.
    Spindelegger CJ; Papageorgiou K; Grohmann R; Engel R; Greil W; Konstantinidis A; Agelink MW; Bleich S; Ruether E; Toto S; Kasper S
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ; Islam K
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
    Truong J; Yan AT; Cramarossa G; Chan KK
    Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natur a l Substitutes.
    Bahmani M; Sarrafchi A; Shirzad H; Asgari S; Rafieian-Kopaei M
    Curr Pharm Des; 2017; 23(6):952-960. PubMed ID: 27719647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac side effects of psychiatric drugs.
    Mackin P
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():3-14. PubMed ID: 18098218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of systemic cancer treatment.
    Senkus E; Jassem J
    Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents.
    Alzayer R; Hughes J; Parsons R; Lee YP
    Qual Prim Care; 2010; 18(3):189-99. PubMed ID: 20659403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.